New Haven, CT2 Active Studies

Atrial Fibrillation Clinical Trials in New Haven, CT

Find 2 actively recruiting atrial fibrillation clinical trials in New Haven, CT. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
3,320
Enrolling

Recruiting Atrial Fibrillation Studies in New Haven

About Atrial Fibrillation Clinical Trials in New Haven

Atrial fibrillation (AFib) is the most common type of heart arrhythmia, causing an irregular and often rapid heartbeat. It significantly increases the risk of stroke, heart failure, and other complications. Treatment includes blood thinners, heart rate or rhythm control medications, and procedures like ablation.

There are currently 2 atrial fibrillation clinical trials recruiting participants in New Haven, CT. These studies are seeking a combined 3,320 participants. Research is being sponsored by Icahn School of Medicine at Mount Sinai, Incyte Corporation. Clinical trial participation is free and participants receive study-related medical care at no cost.

Atrial Fibrillation Clinical Trials in New Haven — FAQ

Are there atrial fibrillation clinical trials in New Haven?

Yes, there are 2 atrial fibrillation clinical trials currently recruiting in New Haven, CT. Browse the studies on this page to find one that fits.

How do I join a clinical trial in New Haven?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New Haven research site will contact you about next steps.

Are clinical trials in New Haven free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New Haven studies also compensate for your time and travel.

What atrial fibrillation treatments are being tested?

The 2 active trials in New Haven are testing new therapies including novel drugs, biologics, and treatment approaches for atrial fibrillation.

Data updated March 2, 2026 from ClinicalTrials.gov